Commit To Buy Sage Therapeutics At $35, Earn 16.9% Annualized Using Options

Investors eyeing a purchase of Sage Therapeutics Inc (SAGE) shares, but cautious about paying the going market price of $46.60/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May 2017 put at the $35 strike, which has a bid at the time of this writing of $3.80..